Acid sphingomyelinase regulates osteoclastogenesis by modulating sphingosine kinases downstream of RANKL signaling

Biochemical and Biophysical Research Communications

Volumn 405, Issue 4, 2011, Pages 533-537

  Bao, Xilinqiqige ^a   Ogawa, Takuya ^a   Se, Satoru ^a   Akiyama, Motofusa ^a   Bahtiar, Anton ^a   Takeya, Tatsuo ^a   Ishida Kitagawa, Norihiro ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Acid sphingomyelinase; C Fos; Ceramide; NFAT2; Sphingosine kinase

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; SHORT HAIRPIN RNA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CATALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; MOUSE; MULTINUCLEAR CELL; NONHUMAN; ONCOGENE C FOS; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RANK LIGAND; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 79951957217     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.061     Document Type: Article

References (20)

1. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., Kumegawa M., Kimura T., Takeya T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 2002, 277:41147-41156.
2. Ogawa T., Ishida-Kitagawa N., Tanaka A., Matsumoto T., Hirouchi T., Akimaru M., Tanihara M., Yogo K., Takeya T. A novel role of L-serine (L-Ser) for the expression of nuclear factor of activated T cells (NFAT)2 in receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclastogenesis in vitro. J. Bone Miner. Metab. 2006, 24:373-379.
3. Kitatani K., Idkowiak-Baldys J., Hannum Y.A. The sphingolipids salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008, 20:1008-1010.
4. Hait N.C., Oskeritzian C.A., Paugh S.W., Milsien S., Spiegel S. Sphingosine kinases, sphingosine 1-phosphates apoptosis and diseases. Biochimica et Biophysica Acta 2006, 1758:2016-2026.
5. Bahtiar A., Matsumoto T., Nakamura T., Akiyama M., Yogo K., Ishida-Kitagawa N., Ogawa T., Takeya T. Identification of a novel L-Serine analog that suppresses osteoclastogenesis in vitro and bone turnover in vivo. J. Biol. Chem. 2009, 284:34157-34166.
6. Ishida N., Hayashi K., Hattori A., Yogo K., Kimura T., Takeya T. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J. Bone Miner. Res. 2006, 21:48-57.
7. Zeidan Y.H., Hannun Y.A. The acid sphingomyelinase/ceramide pathway biomedical significance and mechanisms of regulation. Curr. Mol. Med. 2010, 10:454-466.
8. Kohama T., Olivera A., Edsall L., Nagiec M.M., Dickson R., Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol. Chem. 1998, 273:23722-23728.
9. Liu H., Sugiura M., Nava V.E., Edsall L.C., Kono K., Poulton S., Milstein S., Kohama T., Spiegel S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 2000, 275:19513-19520.
10. Maceyka M., Sankala H., Hait N.C., Le Stunff H., Liu H., Toman R., Collier C., Zhang M., Satin L.S., Merrill A.H., Milstien S., Spiegel S. SphK1 and SphK2 sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol Chem. 2005, 280:37118-37129.
11. Hait N.C., Allegood J., Maceyka M., Strub G.M., Harikumar K.B., Singh S.K., Luo C., Marmorstein R., Kordula T., Milstien S., Spiegel S. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 2009, 325:1254-1257.
12. Sauane M., Su Z.Z., Dash R., Liu X., Norris J.S., Sarkar D., Lee S.G., Allegood J.C., Dent P., Spiegel S., Fisher P.B. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer specific apoptosis. J. Cell. Phys. 2009, 222:546-555.
13. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
14. Spiegel S., Milstien S. Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem. Soc. Trans. 2003, 31:1216-1219.
15. Takeda H., Ozaki K., Yasuda H., Ishida M., Kitano S., Hanazawa S. Sphingomyelinaze and ceramide inhibit formation of F-actin ring in and bone resorption by rabbit mature osteoclasts. FEBS Lett. 1998, 422:255-258.
16. Nemoto S., Nakamura M., Osawa Y., Kono S., Itoh Y., Okano Y., Murate T., Hara A., Ueda H., Nozawa Y., Banno Y. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. J. Biol. Chem. 2009, 284:10422-10432.
17. Pitson S.M., Moretti P.A., Zebol J.R., Xia P., Gamble J.R., Vadas M.A., D'Andrea R.J., Wattenberg B.W. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation a dominant-negative sphingosine kinase. J. Biol. Chem. 2000, 275:33945-33950.
18. Okada T., Ding G., Sonoda H., Kajimoto T., Haga Y., Khosrowbeygi A., Gao S., Miwa N., Jahangeer S., Nakamura S. Involvement of N-terminal-extended form of sphingosine kinase 2 I serum-dependent regulation of cell proliferation and apoptosis. J. Biol. Chem. 2005, 280:36318-36325.
19. Teitelbaum S.L. Osteoclasts: what do they do and how do they do it?. Am. J. Pathol. 2007, 170:427-435.
20. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006, 25:5840-5851.